Former head of Medicaid exposes America's insurance crisis

01The scale of America's uninsured problem

The United States is the wealthiest nation on Earth, yet approximately 27 million Americans — roughly 8% of the population — have no health insurance at any given time. Millions more are underinsured, holding plans with deductibles and copays so high that they effectively cannot afford to use their coverage. This is not a fringe problem; it is a structural feature of a system that treats healthcare as a commodity rather than a right.

Medicaid is the government program that provides health insurance for adults and children with limited income and resources. It is partially funded and primarily managed by state governments, which have wide latitude in determining eligibility and benefits, though the federal government sets baseline standards and provides a significant portion of funding. States are not required to participate, though all have since 1982. The Affordable Care Act's Medicaid expansion, adopted by 40 states and Washington D.C. as of 2026, extended eligibility to adults earning up to 138% of the federal poverty level.

The ten states that have not expanded Medicaid are concentrated in the South, leaving an estimated 2.2 million people in a "coverage gap" — earning too much for traditional Medicaid but too little to qualify for subsidized marketplace insurance. These are disproportionately Black and Hispanic Americans, perpetuating racial disparities in healthcare access and outcomes.

Chart 1 — US per-capita healthcare spending vs peer nations

02How insurance denials harm patients

Health insurance is a type of insurance that covers the whole or a part of the risk of a person incurring medical expenses. In theory, risk is shared among many individuals — by estimating the overall risk of health expenses over the risk pool, an insurer can develop a routine finance structure, such as a monthly premium, to provide the money to pay for the healthcare benefits specified in the insurance agreement. In practice, American health insurers routinely deny coverage for medically necessary care, creating a gap between what policies promise and what patients receive.

Denial tactics include prior authorization requirements that delay urgent treatment, retroactive claims revocation (rescission), narrow provider networks that push patients out of pocket, and arbitrary medical necessity determinations that override treating physicians. A 2023 KFF study found that insurers denied roughly 17% of in-network claims, with denial rates varying dramatically by insurer — some exceeding 30%. Appeals are successful only about half the time, and many patients never appeal because the process is deliberately opaque and exhausting.

The human cost is measurable. Studies link insurance denials to delayed cancer diagnoses, untreated chronic conditions, and avoidable emergency hospitalizations. A 2022 survey by the Commonwealth Fund found that 38% of working-age Americans skipped or delayed care due to cost, and 29% reported medical debt. Denials do not merely deny claims — they deny care, and denied care in the American system often means no care at all.

03Medicaid expansion and its impact

The Affordable Care Act's Medicaid expansion is the single most effective policy for reducing uninsurance in the past decade. States that expanded Medicaid saw uninsured rates drop by 7 to 9 percentage points, emergency room visits for primary-care-preventable conditions decline, and rural hospital closures slow. The federal government pays 90% of expansion costs, making it one of the most fiscally efficient coverage mechanisms available.

Despite this, ten holdout states — primarily in the South — have refused expansion. The consequences are severe: uninsured rates in these states average 12% versus 8% in expansion states. Rural hospitals in non-expansion states close at twice the rate of those in expansion states, because they bear the cost of uncompensated care. The decision not to expand Medicaid is simultaneously a fiscal decision, a racial-justice issue, and a public-health crisis.

The former Medicaid director who speaks in the source video describes expansion as "the most successful thing I ever worked on" — but notes that even expansion states face challenges: low reimbursement rates that discourage physician participation, administrative barriers that cause eligible people to lose coverage, and the continuous-enrollment unwinding that followed the COVID-19 public health emergency, which removed over 20 million people from Medicaid rolls beginning in 2023.

04The pharmacy benefit manager scandal

A pharmacy benefit manager (PBM) is a third-party administrator of prescription drug programs for commercial health plans, self-insured employer plans, Medicare Part D plans, the Federal Employees Health Benefits Program, and state government employee plans. PBMs operate inside integrated healthcare systems, as part of retail pharmacies, and as part of insurance companies. The three largest PBMs — CVS Caremark, Express Scripts, and OptumRx — control over 80% of the market and process roughly 80% of all prescriptions filled in the United States.

PBMs were originally created to negotiate drug discounts and manage formularies on behalf of insurers. Over time, their business model has become opaque and conflicted. PBMs negotiate rebates from drug manufacturers — often 20% to 50% of a drug's list price — but are not required to pass those rebates to patients or employers. Instead, they profit from the spread between what manufacturers charge and what insurers pay, creating an incentive to favor high-list-price drugs that generate larger rebates. This "rebate trap" inflates drug prices and increases patient cost-sharing.

Vertical integration compounds the problem. CVS Caremark is owned by CVS Health, which also owns Aetna insurance and CVS pharmacies. OptumRx is owned by UnitedHealth Group, which also owns UnitedHealthcare insurance. This means the company negotiating drug prices, the company paying for drugs, and the company selling drugs can be the same entity — with no transparency for patients or employers about where the money flows. The FTC's 2024 interim report on PBMs found that their practices have contributed to higher drug costs, pharmacy closures, and reduced patient access.

05Surprise billing and medical debt

Surprise billing occurs when patients receive care from an out-of-network provider at an in-network facility — typically in emergencies where patients cannot choose their provider. Before the No Surprises Act (effective 2022), this practice saddled patients with bills running tens of thousands of dollars. The law established an independent dispute resolution process, but enforcement has been uneven, and loopholes remain for ground ambulance services, which are exempt from the law's protections.

Medical debt is the leading cause of personal bankruptcy in the United States. A 2022 Stanford study found that Americans held approximately $195 billion in medical debt — more than all other forms of consumer debt combined except mortgages. Black households carry medical debt at 2.5 times the rate of white households. The South, which has the highest uninsured rates, also has the highest medical debt burden.

Chart 2 — In-network claim denial rates by major insurer

Three states — Colorado, Oregon, and New York — have banned medical debt from credit reports. Federal action has been limited: the CFPB proposed a national rule in 2024 to remove medical debt from credit reports, but implementation faces industry opposition. The fundamental problem is structural: a system that prices care beyond what patients can afford will inevitably produce debt, and no ban on credit reporting fixes the underlying unaffordability.

06What reforming the system requires

The former Medicaid director in the source video identifies three pillars of reform: universal coverage, price controls, and administrative simplification. Universal coverage means closing the Medicaid gap and ensuring every American has insurance that is usable — not merely a card that provides the illusion of coverage. Price controls mean addressing the fact that American healthcare prices are 2 to 3 times those of peer nations for identical services and drugs. Administrative simplification means reducing the overhead — estimated at 15% to 30% of total healthcare spending — consumed by billing, prior authorization, utilization review, and insurance company profits.

None of these reforms are politically simple. Universal coverage requires new spending or redistribution from current stakeholders — insurers, pharmaceutical companies, and PBMs — who profit from the status quo and spend billions lobbying to preserve it. Price controls challenge the market-based pricing ideology that has dominated American healthcare policy for decades. Administrative simplification threatens the jobs and revenue streams of millions of people who work in billing, coding, and insurance administration.

The single-payer Medicare for All proposal addresses all three pillars but faces political opposition from both the healthcare industry and moderate legislators who prefer incremental reform. Public option proposals — a government-run insurance plan competing with private insurers — are a compromise that expands coverage without dismantling the private market. Neither approach has the votes to pass in the current Congress, though support grows with each healthcare crisis that makes national news.

07Lessons from other countries' healthcare

Every other developed nation achieves universal or near-universal coverage at lower per-capita cost than the United States. The models differ: the UK's National Health Service is a single-payer system with government-owned hospitals and salaried physicians. Canada's Medicare is single-payer for insurance but with private providers. Germany uses a multi-payer system with mandatory sickness funds — nonprofit insurers regulated as public utilities. Japan employs a statutory insurance system with fee schedules set by the government. Australia combines a public universal system (Medicare) with private insurance for those who want it.

The common thread is not the specific structure but the principles: universal enrollment, regulated prices, and administrative simplicity. No peer nation allows PBM rebate retention, prior authorization at current American rates, or surprise billing. No peer nation spends 17% of GDP on healthcare (the U.S. figure) while leaving 8% of its population uninsured. The gap is not a failure of American medicine — American hospitals and physicians are world-class — but a failure of American healthcare financing.

The source video's most striking moment is the former Medicaid director's observation that the American system is not broken — it is working as designed. It is designed to generate profit for insurers, PBMs, and pharmaceutical companies, and it does so extraordinarily effectively. Reform is not a technical problem of policy design; it is a political problem of power. Until the political coalition exists to override the concentrated economic interests that benefit from the current system, tens of millions of Americans will remain uninsured, underinsured, and in medical debt — in the wealthiest nation on Earth.